// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Identification of synovial fibroblasts subsets associated with pain and progression of knee osteoarthritis by single cell sequencing

D.E. Nanus - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Involvement of patella damage in pain sensitisation and treatment outcome in knee osteoarthritis

F.A. Howe - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Knee osteoarthritis

N/A

Subcutaneous tanezumab 2.5 MG or 5 MG for patients with osteoarthritis of the knee or hip: onset and maintenance of efficacy over 24 weeks

F. Berenbaum - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Prospective post market data collection on patients with knee osteoarthrtis treated with autologous protein solution (APS) (progress III study)

V. Vedi - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Stakeholder opinion of care pathways to increase physical activity in individuals with knee osteoarthritis in Saudi Arabia

M. Subahi - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Moderators of the effects of exercise for hip and knee osteoarthritis: a systematic review of subgroup analyses from randomised controlled trials

J.G. Quicke - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Standardised reporting of kinematic waveform data from a portable movement analysis toolkit: informing physiotherapy decision making

K. Button - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Growth factor release upon cartilage injury is due to aggrecan-dependent sodium flux that is lost in osteoarthritis

S.J. Keppie - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

Interleukin

The use of a 3-dimensional mechanical loading model of human stem cell derived osteocytes to study the ‘mechanosome’

S. Gilbert - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Sclerosteosis

Dexamethasone

Investigation of the chondrocyte response to varying mechanical load: assessment of impact stress

S.M. Higgins - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

streptomycin

Regional and compartmentalized variation of subchondral bone mineralization and microarchitecture in hip osteoarthritis

Y. Li - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Poly-phosphocholinated liposomes form stable lubrication vectors with enhanced retention in joints

W. Lin - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

LT 02

Quick and accurate evaluation of cartilage histopathology on undecalcified osteochondral tissue

Y. Li - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Analysis of extracellular matrix and mineral composition in primary osteoarthritic osteoblasts and their native subchondral bones by Raman spectroscopy

N. Che Ahmad Tantowi - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

streptomycin

Small non-coding RNA signatures of healthy and diseased anterior cruciate ligament

Y. Ashraf Kharaz - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Acrocallosal syndrome

N/A

Semaphorin-3A expression is up-regulated in innervated joint tissues during the development of osteoarthritis

X. Li - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Neuromuscular alterations in knee osteoarthritis: a systematic review and meta-analysis

B. Tayfur - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

How does neuromuscular function change over time following knee injuries? a systematic review and meta-analysis

B. Tayfur - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Inter-individual variation in hip flexor length may explain differences in trunk flexion during walking in people with knee osteoarthritis

S.J. Preece - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

Orphenadrine Citrate

The development of a new EMG biofeedback intervention for people with knee osteoarthritis

S.J. Preece - Osteoarthritis Research Society International (OARSI) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Copyright © 2026. QuantiNova All rights reserved